Hopkins researchers are validating a nanosensor platform to detect SARS-CoV-2 and other viruses that consists of a single-use chip and handheld spectrometer.
The startup is kicking off clinical validation studies for a single-use, at-home testing platform that uses up to 32 graphene biosensors within a poker chip-sized fluidic cartridge.